Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma.
By Jin-Ching Lin, Wen-Yi Wang, Kuang Y. Chen, Yau-Huei Wei, W. Liang, J. Jan, R. Jiang. New England Journal of Medicine, 2004
837 citations recorded by the source corpus.
Subfields: Oncology, Otorhinolaryngology
View Paper: https://www.semanticscholar.org/paper/647cdf8b0e495d8a41017f1f8c5b9f0db887e498
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- humAn cArcinogens
- peRsonAl hAbIts
- Iarc Monographs
- E. Chang
- H. Adami
Citations in the corpus
- The Enigmatic Epidemiology of Nasopharyngeal Carcinoma (2006, background): “More recently, circulating cell-free EBV DNA has been detected in a higher proportion of NPC patients than controls (92-95), and levels are positively correlated with disease stage and prognosis (92-97), although prospective studies of predisease levels have yet to be done.”
- iArc monogrAphs on the evAluAtion oF cArcinogenic risks to humAns (2012, background): “EBV-associated cancers, the EBV-genome load found in the peripheral blood lymphocytes or plasma precedes the development of malignancy (Lin et al., 2004).”